Kevin Courtney

Kevin Courtney

UNVERIFIED PROFILE

Are you Kevin Courtney?   Register this Author

Register author
Kevin Courtney

Kevin Courtney

Publications by authors named "Kevin Courtney"

Are you Kevin Courtney?   Register this Author

28Publications

649Reads

7Profile Views

Salvage Radiotherapy for Nodal Oligorecurrent Prostate Cancer: A Step Towards Predictive Criteria for Metastasis-Directed Therapy in Prostate Cancer?

Eur Urol 2019 Dec 14;76(6):740-742. Epub 2019 Aug 14.

Departments of Urology and Radiology, University of Texas Southwestern, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.07.050DOI Listing
December 2019

Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases.

Clin Genitourin Cancer 2019 04 5;17(2):e263-e272. Epub 2018 Dec 5.

Kidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX; Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.11.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534272PMC
April 2019

Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo.

Cell Metab 2018 11 23;28(5):793-800.e2. Epub 2018 Aug 23.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA; Annette G. Strauss Center for Neuro-Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2018.07.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221993PMC
November 2018

Comment on 'Orthogonal lipid sensors identify transbilayer asymmetry of plasma membrane cholesterol'.

Elife 2018 11 13;7. Epub 2018 Nov 13.

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7554/eLife.38493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257810PMC
November 2018

Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.

J Clin Oncol 2018 03 19;36(9):867-874. Epub 2017 Dec 19.

Kevin D. Courtney and James Brugarolas, University of Texas Southwestern Medical Center; Naseem J. Zojwalla, Ann M. Lowe, Keshi Wang, Eli M. Wallace, and John A. Josey, Peloton Therapeutics, Dallas, TX; Jeffrey R. Infante, TN Oncology and Sarah Cannon Research Institute, Nashville, TN; Elaine T. Lam, University of Colorado Cancer Center, Aurora, CO; Robert A. Figlin, Cedars-Sinai Medical Center, Los Angeles, CA; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Toni K. Choueiri, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.2627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946714PMC
March 2018

mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells.

Proc Natl Acad Sci U S A 2017 07 10;114(30):7999-8004. Epub 2017 Jul 10.

Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, ON, Canada K1H 8L6;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1705304114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544314PMC
July 2017

Akt inhibition promotes ABCA1-mediated cholesterol efflux to ApoA-I through suppressing mTORC1.

PLoS One 2014 21;9(11):e113789. Epub 2014 Nov 21.

Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0113789PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240609PMC
December 2015

Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Can J Urol 2015 Aug;22(4):7865-75

Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
August 2015

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer.

Clin Genitourin Cancer 2015 Apr 22;13(2):113-23. Epub 2014 Oct 22.

Medical Oncology, Dana-Farber Cancer Institute and Internal Medicine, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418946PMC
April 2015

Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer.

BJU Int 2012 Dec 29;110(11):1729-35. Epub 2012 Aug 29.

Lank Center for Genitourinary Oncology, Department of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11456.xDOI Listing
December 2012

The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer.

Curr Opin Oncol 2012 May;24(3):272-7

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328351059dDOI Listing
May 2012

Determining a minimum detection threshold in terminal restriction fragment length polymorphism analysis.

J Microbiol Methods 2012 Jan 8;88(1):14-8. Epub 2011 Oct 8.

Department of Integrative Biology, University of Guelph, 50 Stone Road East, Guelph, ON, Canada N1G 2 W1.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01677012110035
Publisher Site
http://dx.doi.org/10.1016/j.mimet.2011.09.016DOI Listing
January 2012

Updates on novel therapies for metastatic renal cell carcinoma.

Ther Adv Med Oncol 2010 May;2(3):209-19

Dana-Farber Cancer Institute, Brigham & Women's Hospital, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834010361470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126014PMC
May 2010

The PI3K pathway as drug target in human cancer.

J Clin Oncol 2010 Feb 19;28(6):1075-83. Epub 2010 Jan 19.

Massachusetts General Hospital Cancer Center, 149 13th St, Charlestown, 02129, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.3641DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834432PMC
February 2010

Optimizing recent advances in metastatic renal cell carcinoma.

Curr Oncol Rep 2009 May;11(3):218-26

Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-009-0031-5DOI Listing
May 2009

PI3K enters beta-testing.

Cell Metab 2008 Sep;8(3):179-81

Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2008.08.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389549PMC
September 2008

Pulmonary thrombectomy in a patient with hemoglobin Nottingham.

Perfusion 2007 Jul;22(4):299-301

Department of Anesthesiology, Perioperative and Pain Medicine, Division of Cardiac Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0267659107084143DOI Listing
July 2007